Investors

Where Innovation Meets Impact.

AI-Powered Platforms Transforming Digital Health and Driving Shareholder Value

Why Invest in AIML?

(CSE: AIML | OTCQB: AIMLF | FWB: 42FB)

We are pioneering the future of health intelligence by developing and commercializing advanced AI-driven technologies that unlock powerful biometric insights

Backed by a growing portfolio of proprietary technologies and a world-class leadership team, AIML is committed to delivering long-term value to shareholders while improving health outcomes across global markets.

Corporate Governance

Capital Structure

October 21, 2025

AIML Subsidiary NeuralCloud Solutions Commencing Pilot with Canadian Cardiology Clinic to Advance AI-Powered ECG Reporting

Press Releases

Read more in Archive

October 21, 2025

AIML Subsidiary NeuralCloud Solutions Commencing Pilot with Canadian Cardiology Clinic to Advance AI-Powered ECG Reporting

October 15, 2025

AIML Subsidiary NeuralCloud Solutions and Heartdent Center Ltd. Launch Pilot Project to Advance Cardiac Care in Jamaica

October 7, 2025

AIML Subsidiary NeuralCloud Solutions and Toronto Heart Centre Launch a Pilot Program to Test AI-Powered Holter ECG Reporting

September 30, 2025

AIML and BC Brain Wellness Program Launch Pilot to Explore the Heart–Brain Connection

September 23, 2025

AIML Announces Closing of Oversubscribed Private Placement

September 4, 2025

AIML Announces Proposed Private Placement

Past Newsletters

Read more in Archive

Corporate Governance

Board of Directors

Paul Duffy

Executive Chairman and CEO

Dr. Drew Dundas

Independent Director

Jared Adelstein

Independent Director

Peter Kendall

Director and CCO

Michael Diamond

Independent Director

Financials

Read more on CSE

AGM Materials

Information Circular

Notice and Access

Form of Proxy

Financial Request Form

Information Circular

Notice and Access

Form of Proxy & Return Card

Notice of Meeting and Information Circular

Form of Proxy and Return Card

Historic AGM materials can be found under the company’s profile on SEDAR+

Charters & Policies

Corporate Disclosure and Insider Trading Policy

Code of Business Conduct and Ethics

Audit Committee Charter

Whistleblower Policy

Company Structure

253.9

Million

Shares Outstanding

16

Million

Options

190.7

Million

Warrants Outstanding

460.6

Million

Fully Diluted

Get in Touch

We are playing a growing role in healthcare, where advanced biomedical signal processing and real-time biometrics empower individuals with unparalleled insights into their well-being. By integrating AI-driven analysis, seamless automation, and ethical data practices, we’re making personalized, preventative care accessible to all.

Whether you’re looking to innovate, collaborate, or explore the limitless potential of biometric intelligence, we’d love to connect—because the next breakthrough in health starts with a conversation.